Press Releases

EAST HANOVER, N.J., March 18, 2020 /PRNewswire/ -- Novartis announced today the publication of three pivotal Phase III clinical trials for inclisiran, a potential first-in-class small interfering RNA (siRNA) investigational agent for hyperlipidemia in adults. The findings were published in two online articles ahead of print in The New England Journal of Medicine.

DALLAS, March 18, 2020 /PRNewswire/ -- Doug Carter, CEO of Ironside Human Resources, today announced Ironside HR has been named as a Best Staffing Firm to Work For winne

ROCKVILLE, Md., March 18, 2020 /PRNewswire/ -- Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to start a Phase 2 clinical trial of Thrombosomes in bleeding patients with thrombocytopenia. In July 2019

BOSTON, March 18, 2020 /PRNewswire/ -- In response to the serious challenges posed by the Coronavirus/COVID-19 pandemic, Blue Cross Blue Shield of

AUSTIN, Texas, March 18, 2020 /PRNewswire/ -- Veteran regenerative medicine industry leader Jodi Gurney, former Executive Vice President and Chief Innovation Officer at Celularity, Inc., has become the new Chief Executive Officer of market-leading biologics producer Direct Biologics

STAMFORD, Conn., March 18, 2020 /PRNewswire/ -- ApiJect Systems America, a public benefit corporation based here, today joined with the U. S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response in announcing the launch of a public-private partnership dedicated to creating a U.S.-based high-speed, high-volume

NEW YORK and BASEL, Switzerland, March 18, 2020 /PRNewswire/ -- Roivant Sciences today announced that it has engaged with regulators in the United States, Europe, and Asia to rapidly advance the clinical development of gimsilumab for the tr

ROCKVILLE, Md., March 18, 2020 /PRNewswire/ -- The U.S. Pharmacopeia (USP) is providing free technical assistance to developers of medical treatments such as antiviral drugs and vaccines that can support the public health response to the COVID-19 pandemic. USP is making its scientific teams available to help developers ensure the quality of their materials as they

OXFORD, England, March 18, 2020 /PRNewswire/ -- After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences ("PacBio") in this litigation.This outcome follows positive outcomes for Oxford Nanopore in previous proceedings.

CHANDLER, Ariz., March 18, 2020 /PRNewswire/ -- SilverSneakers®, the nation's leading community fitness program designed for seniors, is adding digital resources to support its members as the spread of COVID-19 keeps people home and quarantined. On Thursday, March 19 at 8:30 a.m. MST, we will kick of